BackArch Biopartners Overview

Arch Biopartners Total Liabilities

Track Arch Biopartners's total liabilities ($4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$4.04M
↑ 3.03% YoYΔ $118900.00 vs prior year quarter

Peer trimmed avg / median

Loading

Arch Biopartners Total Liabilities History

Loading

Arch Biopartners vs. peers: Total Liabilities Comparison

Loading

Arch Biopartners Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Arch Biopartners (ARCH.V) FAQ

Arch Biopartners posts a total liabilities of $4M as of June 2026. That compares with $3.9M in the prior-year period — up 3.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Arch Biopartners's total liabilities was $3.9M. The latest reading is $4M — a 3.0% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of Arch Biopartners's financial statement story. At $4M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ARCH.V's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Arch Biopartners's other metric pages and overview cover the third.

Judging Arch Biopartners against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in total liabilities easier to interpret. Start with $4M here, then scan peer and history charts to see if the gap is persistent.